Endocrine disrupting compounds and prostate cancer

This publication has 129 references indexed in Scilit:

• Structural basis for antagonism and resistance of bicalutamide in prostate cancer
  Proceedings of the National Academy of Sciences, 2005
• Molecular determinants of resistance to antiandrogen therapy
  Nature Medicine, 2003
• Antiproliferative Effect of Resveratrol in Human Prostate Carcinoma Cells
  Journal of Medicinal Food, 2003
• Normal Sexual Development of Two Strains of Rat Exposed in Utero to Low Doses of Bisphenol A
  Toxicological Sciences, 2002
• Expression of prostate‐specific antigen is transcriptionally regulated by genistein in prostate cancer cells
  Molecular Carcinogenesis, 2002
• Lack of significant alteration in the prostate or testis of F344 rat offspring after transplacental and lactational exposure to bisphenol A.
  The Journal of Toxicological Sciences, 2002
• Phytoestrogen intake and prostate cancer: A case‐control study using a new database
  Nutrition and Cancer, 1999
• Influence of isoflavones in soy protein isolates on development of induced prostate‐related cancers in L‐W rats
  Nutrition and Cancer, 1997
• Persistent DDT metabolite p,p'–DDE is a potent androgen receptor antagonist
  Nature, 1995
• Chromosomal aberrations and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. IV. Results with 15 chemicals
  Environmental and Molecular Mutagenesis, 1989